Korro Bio, Inc. (KRRO) Free cash flow 2017–2025
Korro Bio, Inc. (KRRO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$79.1MFY2025 · since FY2017: -$16.5M → -$79.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.1M | -1.4% |
| FY2024 | -$78.0M | -3.8% |
| FY2023 | -$75.1M | -27.8% |
| FY2022 | -$58.8M | +25.6% |
| FY2021 | -$79.0M | -52.3% |
| FY2020 | -$51.9M | -256.4% |
| FY2019 | $33.2M | +289.9% |
| FY2018 | -$17.5M | -6.0% |
| FY2017 | -$16.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice